SELLAS Life SciencesvsUnitedHealth

SLS and UNH stock compared: price, dividend, valuation and results, from SEC filings.

SLS

SELLAS Life Sciences Group, Inc.

$14.86

Value $3.0B

-17.21%
SLS's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

SELLAS Life Sciences (SLS) has a market value of $3.0B and UnitedHealth (UNH) $300B. Over the last year, with dividends, SLS moved +834.6% and UNH +8.2%. Dividend yield: SLS none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SLS$3.0B

    UNH$300B

    UNH is 99 times SLS

  • Revenue, 12 months

    SLS–

    UNH$450B

  • Net income, 12 months

    SLS-$36M

    UNH$15.9B

  • Operating margin

    SLS–

    UNH5.3%

  • ROIC

    SLS-31.5%

    UNH11.3%

    42.8 points apart

  • P/E

    SLS–

    UNH18.9

  • Dividend yield

    SLS0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    SLS+116.3%

    UNH-19.5%

    135.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SLS+108.3%

UNH-19.5%

010020020222023202420252026
Returns by period
PeriodSLSWith dividendsUNHWith dividends
1 year since November 18, 2025+834.6%Price +834.6%+8.2%Price +5.4%
3 years since November 17, 2023+1,401.0%+146.7% a yearPrice +1,401.0%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021+116.3%+16.7% a yearPrice +116.3%-19.5%-4.2% a yearPrice -26.5%
10 years since November 21, 2016-99.7%-45.0% a yearPrice -99.7%+159.4%+10.0% a yearPrice +119.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SLSSELLAS Life SciencesUNHUnitedHealth

Valuation

SLSUNH
Valuation
Price$14.86$330.48
Market value$3.0B$300B
Enterprise value (EV)$2.9B$346B
P/E–18.9
P/E, 5-year median–25.0
P/B23.02.9
EV/EBIT–14.5
Free cash flow yield–7.6%

Results and growth

SLSUNH
Results and growth
Revenue, 12 months–$450B
Net income, 12 months-$36M$15.9B
Free cash flow, 12 months-$27M$22.8B
Earnings per share, 12 months-$0.20$17.52
Revenue growth, year on year-100.0%11.8%
Revenue growth a year, past–+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

SLSUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin–5.3%
Net margin–3.5%
ROIC-31.5%11.3%
ROE-36.2%15.5%

Balance sheet

SLSUNH
Balance sheet
Cash$135M$28.5B
Total debt$599.0K$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

SLSUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SLS or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, SELLAS Life Sciences or UnitedHealth?

By market value, UnitedHealth ($300B) is about 99.0 times SELLAS Life Sciences ($3.0B), at today's prices.

How did SLS and UNH stock do over the last 10 years?

Since November 21, 2016, SLS's price moved -99.7% and UNH's +119.7%. With dividends: SLS -99.7% (-45.0% a year), UNH +159.4% (+10.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, SLS or UNH?

The dividend yield at today's price is none for SELLAS Life Sciences and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which is the better investment, SELLAS Life Sciences or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.